CD274 and neoplasm: Therefore, we suggest that a blockage of PD1/PDL1 interaction during/or after MLN4924 treatment may significantly improve the efficiency of MLN4924 therapy via the reduction of PD1/PDL- dependent immune cell energy and the promotion of anti-tumor immunity.